American Health Packaging recalls Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manuf
Recalled July 17, 2019 · FDA recall D-1467-2019 · American Health Packaging
Hazard
GMP Deviations: Potential cross contamination due to cleaning procedure failure. · FDA Class II
Units
375,921 bottles
Sold at
Nationwide USA
Description
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Product
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Manufacturer(s)
American Health Packaging
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →